全文获取类型
收费全文 | 8901篇 |
免费 | 629篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 274篇 |
妇产科学 | 208篇 |
基础医学 | 1307篇 |
口腔科学 | 82篇 |
临床医学 | 1296篇 |
内科学 | 1827篇 |
皮肤病学 | 132篇 |
神经病学 | 907篇 |
特种医学 | 295篇 |
外科学 | 777篇 |
综合类 | 77篇 |
一般理论 | 8篇 |
预防医学 | 1032篇 |
眼科学 | 132篇 |
药学 | 504篇 |
中国医学 | 17篇 |
肿瘤学 | 595篇 |
出版年
2023年 | 74篇 |
2022年 | 126篇 |
2021年 | 239篇 |
2020年 | 136篇 |
2019年 | 235篇 |
2018年 | 261篇 |
2017年 | 194篇 |
2016年 | 207篇 |
2015年 | 249篇 |
2014年 | 286篇 |
2013年 | 405篇 |
2012年 | 633篇 |
2011年 | 591篇 |
2010年 | 330篇 |
2009年 | 313篇 |
2008年 | 503篇 |
2007年 | 560篇 |
2006年 | 467篇 |
2005年 | 505篇 |
2004年 | 492篇 |
2003年 | 489篇 |
2002年 | 417篇 |
2001年 | 123篇 |
2000年 | 132篇 |
1999年 | 134篇 |
1998年 | 91篇 |
1997年 | 66篇 |
1996年 | 67篇 |
1995年 | 78篇 |
1994年 | 41篇 |
1993年 | 56篇 |
1992年 | 55篇 |
1991年 | 58篇 |
1990年 | 58篇 |
1989年 | 49篇 |
1988年 | 51篇 |
1987年 | 44篇 |
1986年 | 47篇 |
1985年 | 49篇 |
1984年 | 50篇 |
1983年 | 40篇 |
1982年 | 41篇 |
1981年 | 28篇 |
1980年 | 30篇 |
1978年 | 22篇 |
1976年 | 32篇 |
1974年 | 29篇 |
1973年 | 23篇 |
1972年 | 19篇 |
1971年 | 24篇 |
排序方式: 共有9556条查询结果,搜索用时 15 毫秒
101.
Marion?M?SchuiererEmail author Christopher?J?Mann Heidi?Bildsoe Clare?Huxley Simon?M?Hughes 《BMC musculoskeletal disorders》2005,6(1):15
Background
Sporadic and sometimes contradictory studies have indicated changes in satellite cell behaviour associated with the progressive nature of human Duchenne muscular dystrophy (DMD). Satellite cell proliferation and number are reportedly altered in DMD and the mdx mouse model. We recently found that satellite cells in MSVski transgenic mice, a muscle hypertrophy model showing progressive muscle degeneration, display a severe ageing-related differentiation defect in vitro. We tested the hypothesis that similar changes contribute to the gradual loss of muscle function with age in mdx and PMP22 mice, a model of human motor and sensory neuropathy type 1A (HMSN1A). 相似文献102.
Helen M. Macdonald Susan A. New Marion K. Campbell David M. Reid 《Osteoporosis international》2005,16(2):163-171
Weight is recognized as an important factor in determining an individuals risk of osteoporosis. However, little is known about whether weight or weight change influences bone loss around the time of the menopause, and the relationship with energy intake and physical activity level remains largely undefined. Healthy premenopausal women (1,064 selected from a random population of 5,119 women aged 45–54 years at baseline) each had bone mineral density (BMD), weight and height measurements, and completed a food frequency and physical activity questionnaire. Of the original participants, 907 women (85.2%) returned 6.3 ± 0.6 years later for repeat BMD measurements, and 896 women completed the questionnaires. Bone loss at the hip (FN) and spine (LS) occurred before the menopause. Weight change rather than weight was associated with FN BMD loss (r=0.102, p=0.002), but weight at follow-up was associated with LS BMD change (r=0.105, p=0.002). Although an increase in physical activity level (PAL) appeared to be beneficial for FN BMD in women who were heavy weight gainers, PAL was associated with increased LS BMD loss in women who lost weight. For current HRT users, neither weight nor weight change was associated with change in BMD. Postmenopausal women not taking HRT should be made aware that low body weight or losing weight during this particularly vulnerable period may worsen bone loss. 相似文献
103.
104.
Mateos MV Hernández JM Hernández MT Gutiérrez NC Palomera L Fuertes M Garcia-Sanchez P Lahuerta JJ de la Rubia J Terol MJ Sureda A Bargay J Ribas P Alegre A de Arriba F Oriol A Carrera D García-Laraña J García-Sanz R Bladé J Prósper F Mateo G Esseltine DL van de Velde H San Miguel JF 《Haematologica》2008,93(4):560-565
105.
Spatial heterogeneity of myocardial perfusion predicts local potassium channel expression and action potential duration 总被引:1,自引:0,他引:1
AIMS: In the heart, there is not only a transmural gradient of left ventricular perfusion and action potential duration (APD), but also spatial heterogeneity within each myocardial layer, where local blood flow and energy turnover vary more than three-fold between individual regions. We analysed at high spatial resolution whether a corresponding heterogeneity also extends to ion channel gene expression and APD. METHODS AND RESULTS: In the open-chest beagle dog, left ventricular 300 microL samples of very low or high flow were identified by radioactive microspheres and expression levels determined by quantitative PCR. The distribution of epicardial APD was assessed by mapping local activation repolarization intervals (ARIs) and QT interval (QT). ERG, the potassium channel mediating IKr, and KChIP2, the interacting protein modulating Ito, were increased in Low flow (3.3- and 2.5-fold, P < 0.001 and <0.05, respectively; n = 6 hearts, 30-31 samples each) as compared with High flow areas. This suggested enhanced repolarizing currents in Low flow areas, and in consequence, mathematical model analysis predicted a shorter local APD upon enhanced ERG and IKr. Epicardial mapping revealed a patchy, temporally stable APD pattern (n = 11), a small apico-basal gradient and an APD prolongation induced by the ERG blocker dofetilide predominantly in areas of short basal ARI or QT, respectively (n = 9). In addition, in Short QT areas, ERG expression was three-fold increased (P < 0.05, n = 4). CONCLUSION: The spatial pattern of perfusion is matched by the novel patterns of K+ channel expression and APD. Whenever this newly recognized intramural dispersion of APD increases, it may contribute to arrhythmogenesis. 相似文献
106.
107.
Reversibility of deficient sleep entrained growth hormone secretion in a boy with achondroplasia and obstructive sleep apnea 总被引:1,自引:0,他引:1
S J Goldstein R H Wu M J Thorpy R J Shprintzen R E Marion P Saenger 《Acta endocrinologica》1987,116(1):95-101
Obstructive sleep apnea may lead to disordered sleep architecture and impair the physiologic slow wave sleep related growth hormone release. Obstructive sleep apnea occurs with craniofacial syndromes and in children with airway narrowing, pharyngeal hypoplasia, tonsillar adenoidal hypertrophy, micrognathia and achondroplasia. To examine the relationship between disordered sleep and growth hormone release we studied a 9 year old male with achondroplasia, growth failure (3 cm/year) and obstructive sleep apnea. Polysomnography data and a 20 min sampling for sleep entrained growth hormone showed before therapeutic tracheostomy numerous apneic episodes, absent slow wave sleep and abnormal low growth hormone secretion during sleep. Normalized slow wave sleep entrained growth hormone secretion after tracheostomy led to a sustained increase in growth rate. Normal growth rate (greater than 5 cm/year) continues 2 years after tracheostomy. We conclude that obstructive sleep apnea may impair sleep related growth hormone release. Obstructive sleep apnea may be a useful model for other diseases in which growth failure and sleep disturbances are linked. 相似文献
108.
Maxence Meyer MD Lidia Calabrese MD Anita Meyer MD Florentin Constancias PhD Louise F. Porter MD PhD Marion Muller Manon Leitner Amandine Leitner Antonin Michaud Georges Kaltenbach MD PhD Elise Schmitt MD PhD Patrick Karcher MD Erik Sauleau MD PhD Saïd Chayer PhD HDR Floriane Zeyons MD Marianne Riou MD Soraya El Ghannudi Abdo MD Frédéric Blanc MD PhD Samira Fafi-Kremer PharmD PhD Aurélie Velay PharmD PhD Thomas Vogel MD PhD 《Journal of the American Geriatrics Society》2021,69(5):1167-1170
109.
110.
Mateos MV García-Sanz R Colado E Olazábal J San-Miguel J 《British journal of haematology》2008,140(3):324-326
Lenalidomide combined with dexamethasone has significant clinical activity in the treatment of multiple myeloma (MM). In previous clinical trials lenalidomide-induced neutropenia was a frequent side-effect, often leading to treatment delays and dose reductions. We describe three MM patients treated with lenalidomide plus dexamethasone, which developed grade 3/4 neutropenia during the initial cycles, but without serious infection. Administration of granulocyte-colony stimulating factor (G-CSF) for 3 d prevented further neutropenia, treatment delays, dose reductions, or infectious complications during the following cycles. Consequently, G-CSF could be effective in preventing further neutropenia-related complications without compromising treatment efficacy in MM patients with lenalidomide-induced neutropenia. 相似文献